Charco Neurotech


CUE1, a non-invasive wearable device for Parkinson’s, utilises pulsed cueing and focused vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement.Developed by a team of engineers, doctors and neuroscientists, CUE1 offers a novel, non-invasive approach to increasing quality of life for people with Parkinson’s. Using removable medical adhesive to rest on the sternum, CUE1 can provide an immediate aid, activated by the simple push of a button.Pilot tests have resulted in an average improvement of 16% in movement tasks such as using tools, manipulating objects, walking and more. Most importantly participants felt their movement was smoother and better controlled.

Based in


Created in

> Website


#Medtech 11.2021


Amadeus Capital Partners, UTEC, Parkwalk Advisors, Crista Galli Ventures & Mint Venture Partners